ProFactor Pharma closed its round of financing in August 2013. The funding was provided principally by members of the Business Angel Syndicate Kelvin Capital, Glasgow, and the Scottish Investment Bank Co-investment Fund. Some of the existing shareholders, including the major shareholder Ingenza Biologics Ltd, also participated in the round.

See the Young Company finance article YCF Article